YanAn Bicon Pharmaceutical Listed Company reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 7,663.19 million compared to CNY 6,953.41 million a year ago. Net loss was CNY 878.88 million compared to CNY 1,070.81 million a year ago. Basic loss per share from continuing operations was CNY 0.4942 compared to CNY 0.6988 a year ago.